L

Lord Clement-Jones (LD)

Speaking in the House of Lords on 11 September 2025

Debate

Merck Research Site

Contribution

My Lords, a narrative is developing: AstraZeneca is relocating to Ireland; the Health Secretary walked out of talks with the industry in August on the voluntary pricing scheme for branded medicines; and now we are seeing this cancellation by Merck. Does this not call into question the whole of the Government’s VPAG policy, which has seen payback rates for new medicines unexpectedly surge to 22.9% in 2025? What are the Irish doing right that this Government should emulate?

More from Lord Clement-Jones (LD)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

Partner sites